Sedation for the critically ill neurologic patient

Research output: Contribution to journalArticle

Abstract

Objective: To review the scientific basis for sedation of critically ill neurologic patients by summarizing the distinct neurophysiologic disturbances present in this population and presenting the central nervous system effects of sedative agents to permit optimal drug therapy. Data Sources: Review of the English language clinical and scientific literature using MEDline data search. Study Selection: Literature references were selected through a key word search of sedative therapy, drugs used for sedation, and specific neurologic disorders and processes to provide an in-depth overview of sedative drug mechanisms of action, effects on neurophysiology and intracranial dynamics, pharmacokinetics, and toxicity profile. Special emphasis was placed on neurologic side effects. Data Extraction: Clinical and scientific literature was reviewed and data relevant to neurophysiologic effects of sedative drug therapy were summarized. Recommendations for institution of sedative therapy and of particular agents were made as a result of analysis of all pooled data. Data Synthesis: Critically ill patients with neurologic pathology present as a unique subset of individuals cared for in an acute care setting. Because monitoring of neurologic patients requires frequent assessment of the neurologic examination, the goal of sedative therapy should he to enhance, or to minimally perturb elicitation of the examination. Neurophysiologic disturbances introduce distinct risks for sedation and require their identification and understanding before the initiation of any sedative therapy. Sedative drugs, in particular, act to disturb central nervous system function and their effects may result in diagnostic confusion and further neurologic deterioration. The pharmacokinetic and neurophysiologic actions of the common classes of sedative agents, such as benzodiazepines, opioids, barbiturates, and neuroleptics, as well as ketamine, propofol, and clonidine are discussed. Recommendations are presented based on the specific type of sedation required and the underlying neurologic disturbance. Several specific examples, including head trauma, neuromuscular disease, and alcohol withdrawal, are provided. Conclusions: Preservation of the neurologic examination is paramount in documenting clinical improvement or deterioration in the critically ill neurologic patient. Pharmacologic sedation in this unique population of acute care patients requires careful consideration of the underlying neurophysiologic disturbances and potential adverse effects introduced by sedative drugs.

Original languageEnglish (US)
Pages (from-to)2038-2053
Number of pages16
JournalCritical Care Medicine
Volume23
Issue number12
DOIs
StatePublished - 1995

Fingerprint

Hypnotics and Sedatives
Critical Illness
Nervous System
Literature
Neurologic Examination
Drug Therapy
Central Nervous System
Pharmacokinetics
Pharmaceutical Preparations
Confusion
Neuromuscular Diseases
Neurophysiology
Barbiturates
Information Storage and Retrieval
Ketamine
Clonidine
Physiologic Monitoring
Propofol
Nervous System Diseases
Benzodiazepines

Keywords

  • barbiturates
  • benzodiazepines
  • clonidine
  • head injury
  • intracranial pressure
  • ketamine
  • neuroleptics
  • neurologic emergencies
  • neurologic examination
  • neuromuscular disease
  • opioids
  • propof ol
  • sedation

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Sedation for the critically ill neurologic patient. / Mirski, Marek A; Muffelman, B.; Ulatowski, John A; Hanley, Daniel F.

In: Critical Care Medicine, Vol. 23, No. 12, 1995, p. 2038-2053.

Research output: Contribution to journalArticle

@article{b34fd1d8aa284a92b895424808005e7a,
title = "Sedation for the critically ill neurologic patient",
abstract = "Objective: To review the scientific basis for sedation of critically ill neurologic patients by summarizing the distinct neurophysiologic disturbances present in this population and presenting the central nervous system effects of sedative agents to permit optimal drug therapy. Data Sources: Review of the English language clinical and scientific literature using MEDline data search. Study Selection: Literature references were selected through a key word search of sedative therapy, drugs used for sedation, and specific neurologic disorders and processes to provide an in-depth overview of sedative drug mechanisms of action, effects on neurophysiology and intracranial dynamics, pharmacokinetics, and toxicity profile. Special emphasis was placed on neurologic side effects. Data Extraction: Clinical and scientific literature was reviewed and data relevant to neurophysiologic effects of sedative drug therapy were summarized. Recommendations for institution of sedative therapy and of particular agents were made as a result of analysis of all pooled data. Data Synthesis: Critically ill patients with neurologic pathology present as a unique subset of individuals cared for in an acute care setting. Because monitoring of neurologic patients requires frequent assessment of the neurologic examination, the goal of sedative therapy should he to enhance, or to minimally perturb elicitation of the examination. Neurophysiologic disturbances introduce distinct risks for sedation and require their identification and understanding before the initiation of any sedative therapy. Sedative drugs, in particular, act to disturb central nervous system function and their effects may result in diagnostic confusion and further neurologic deterioration. The pharmacokinetic and neurophysiologic actions of the common classes of sedative agents, such as benzodiazepines, opioids, barbiturates, and neuroleptics, as well as ketamine, propofol, and clonidine are discussed. Recommendations are presented based on the specific type of sedation required and the underlying neurologic disturbance. Several specific examples, including head trauma, neuromuscular disease, and alcohol withdrawal, are provided. Conclusions: Preservation of the neurologic examination is paramount in documenting clinical improvement or deterioration in the critically ill neurologic patient. Pharmacologic sedation in this unique population of acute care patients requires careful consideration of the underlying neurophysiologic disturbances and potential adverse effects introduced by sedative drugs.",
keywords = "barbiturates, benzodiazepines, clonidine, head injury, intracranial pressure, ketamine, neuroleptics, neurologic emergencies, neurologic examination, neuromuscular disease, opioids, propof ol, sedation",
author = "Mirski, {Marek A} and B. Muffelman and Ulatowski, {John A} and Hanley, {Daniel F}",
year = "1995",
doi = "10.1097/00003246-199512000-00013",
language = "English (US)",
volume = "23",
pages = "2038--2053",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Sedation for the critically ill neurologic patient

AU - Mirski, Marek A

AU - Muffelman, B.

AU - Ulatowski, John A

AU - Hanley, Daniel F

PY - 1995

Y1 - 1995

N2 - Objective: To review the scientific basis for sedation of critically ill neurologic patients by summarizing the distinct neurophysiologic disturbances present in this population and presenting the central nervous system effects of sedative agents to permit optimal drug therapy. Data Sources: Review of the English language clinical and scientific literature using MEDline data search. Study Selection: Literature references were selected through a key word search of sedative therapy, drugs used for sedation, and specific neurologic disorders and processes to provide an in-depth overview of sedative drug mechanisms of action, effects on neurophysiology and intracranial dynamics, pharmacokinetics, and toxicity profile. Special emphasis was placed on neurologic side effects. Data Extraction: Clinical and scientific literature was reviewed and data relevant to neurophysiologic effects of sedative drug therapy were summarized. Recommendations for institution of sedative therapy and of particular agents were made as a result of analysis of all pooled data. Data Synthesis: Critically ill patients with neurologic pathology present as a unique subset of individuals cared for in an acute care setting. Because monitoring of neurologic patients requires frequent assessment of the neurologic examination, the goal of sedative therapy should he to enhance, or to minimally perturb elicitation of the examination. Neurophysiologic disturbances introduce distinct risks for sedation and require their identification and understanding before the initiation of any sedative therapy. Sedative drugs, in particular, act to disturb central nervous system function and their effects may result in diagnostic confusion and further neurologic deterioration. The pharmacokinetic and neurophysiologic actions of the common classes of sedative agents, such as benzodiazepines, opioids, barbiturates, and neuroleptics, as well as ketamine, propofol, and clonidine are discussed. Recommendations are presented based on the specific type of sedation required and the underlying neurologic disturbance. Several specific examples, including head trauma, neuromuscular disease, and alcohol withdrawal, are provided. Conclusions: Preservation of the neurologic examination is paramount in documenting clinical improvement or deterioration in the critically ill neurologic patient. Pharmacologic sedation in this unique population of acute care patients requires careful consideration of the underlying neurophysiologic disturbances and potential adverse effects introduced by sedative drugs.

AB - Objective: To review the scientific basis for sedation of critically ill neurologic patients by summarizing the distinct neurophysiologic disturbances present in this population and presenting the central nervous system effects of sedative agents to permit optimal drug therapy. Data Sources: Review of the English language clinical and scientific literature using MEDline data search. Study Selection: Literature references were selected through a key word search of sedative therapy, drugs used for sedation, and specific neurologic disorders and processes to provide an in-depth overview of sedative drug mechanisms of action, effects on neurophysiology and intracranial dynamics, pharmacokinetics, and toxicity profile. Special emphasis was placed on neurologic side effects. Data Extraction: Clinical and scientific literature was reviewed and data relevant to neurophysiologic effects of sedative drug therapy were summarized. Recommendations for institution of sedative therapy and of particular agents were made as a result of analysis of all pooled data. Data Synthesis: Critically ill patients with neurologic pathology present as a unique subset of individuals cared for in an acute care setting. Because monitoring of neurologic patients requires frequent assessment of the neurologic examination, the goal of sedative therapy should he to enhance, or to minimally perturb elicitation of the examination. Neurophysiologic disturbances introduce distinct risks for sedation and require their identification and understanding before the initiation of any sedative therapy. Sedative drugs, in particular, act to disturb central nervous system function and their effects may result in diagnostic confusion and further neurologic deterioration. The pharmacokinetic and neurophysiologic actions of the common classes of sedative agents, such as benzodiazepines, opioids, barbiturates, and neuroleptics, as well as ketamine, propofol, and clonidine are discussed. Recommendations are presented based on the specific type of sedation required and the underlying neurologic disturbance. Several specific examples, including head trauma, neuromuscular disease, and alcohol withdrawal, are provided. Conclusions: Preservation of the neurologic examination is paramount in documenting clinical improvement or deterioration in the critically ill neurologic patient. Pharmacologic sedation in this unique population of acute care patients requires careful consideration of the underlying neurophysiologic disturbances and potential adverse effects introduced by sedative drugs.

KW - barbiturates

KW - benzodiazepines

KW - clonidine

KW - head injury

KW - intracranial pressure

KW - ketamine

KW - neuroleptics

KW - neurologic emergencies

KW - neurologic examination

KW - neuromuscular disease

KW - opioids

KW - propof ol

KW - sedation

UR - http://www.scopus.com/inward/record.url?scp=0029586784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029586784&partnerID=8YFLogxK

U2 - 10.1097/00003246-199512000-00013

DO - 10.1097/00003246-199512000-00013

M3 - Article

C2 - 7497727

AN - SCOPUS:0029586784

VL - 23

SP - 2038

EP - 2053

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 12

ER -